Joseph Schindler, MD, and Charles Matouk, MD

 SFX Search Buy Article(opens in new window) Permissions and Reprints(opens in new window) Article preview thumbnail

The Guest Editors of this issue of Seminars in Neurology are Drs. Joseph Schindler and Charles Matouk.

Dr. Schindler is Professor of Neurology and Neurosurgery at Yale School of Medicine. He serves in two critical roles for Yale University School of Medicine and Yale New Haven Hospital: he is the Clinical Chief of the Division of Vascular Neurology and Director of the Yale New Haven Comprehensive Stroke Center. He received his MD from Tufts University School of Medicine, followed by his Neurology training at Yale, where he became Chief Resident. After graduation, he trained under the late Lawrence Brass, who established the Stroke Service at Yale. Dr. Schindler is recognized locally, regionally, and nationally as a stroke clinician and program innovator. He has spent the last two decades fortifying the Stroke Program at Yale University and Yale New Haven Hospital and continues to make many academic and clinical contributions. He has received innumerable teaching awards at Yale and beyond. He is widely recognized as an expert in cerebrovascular disease, telemedicine, and carotid artery disease in particular. We are most honored to have Dr. Schindler co-lead this effort in Seminars.

Dr. Matouk is Professor of Neurosurgery and Radiology & Biomedical Imaging at Yale School of Medicine, where he serves as Vice Chair of Clinical Affairs in the Department of Neurosurgery, Chief of Neurovascular Surgery, and Director of the Neurovascular/Endovascular Fellowship. In partnership with Dr. Schindler, he leads one of the largest neurovascular-run carotid revascularization programs in the country. Offering all three modalities of carotid revascularization (CEA, TF-CAS, and TCAR), he tailors his carotid revascularization strategy to clinical circumstances and patient-specific anatomy.

Dr. Matouk has authored over 280 peer-reviewed publications and has a strong track record of NIH- and industry-sponsored clinical and translational research. He has extensive experience in the design, conduct, and oversight of multicenter clinical trials. He actively serves as the national or global PI on several multi-site clinical trials, including in advanced therapies for carotid artery disease.

We hope you find this issue of Seminars in Neurology on Carotid Disease as insightful and cutting-edge as we did. This is a rapidly evolving field that every neurologist needs to stay current on, and this issue provides the ability to do just that, with expert advice for every aspect of carotid disease, from primary stroke prevention to acute treatment. I wish to personally thank Drs. Schindler and Matouk for taking on this effort – I had the great pleasure of working with them both during my time at Yale, and I can attest to how outstanding they both are as clinicians, researchers, educators, and leaders. We hope you enjoy this wonderful issue of Seminars on Neurology!

Article published online:
09 April 2026

© 2026. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

Comments (0)

No login
gif